
Novo Nordisk Egypt has promoted Hassan Fahmi to become its new General Manager for operations within the company. Fahmi arrived …

It is rare to hear bad news in the fight against the spread of HIV, with the global campaign against …

Gill Jennings and Every’s Fiona Stevens discusses recent developments in medical devices regulation and the subsequent impact on IP and …

Roche has announced that its drug Ocrevus (ocrelizumab) has received marketing approval in Switzerland for the treatment of active relapsing …

Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the …

As part of the effort to conduct ethical and scientifically safe, effective clinical trials, the standard for researchers carrying out …

The measles virus has been eliminated from the UK for the first time in the country’s history, according to the …

A new research, funded by the British Heart Foundation, has led to the creation of a new heart attack test …

The destructive forces of Hurricane Maria have caused untold damage to the island nation, with a reported 13 people left …

Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …

The FDA has been very public in its stance that it will look to gain the upper hand in bringing …

New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic …

Operation Pangea X represents an anniversary, of sorts – as it stands as the 10th year of operations by Interpol …

Pfizer has moved to set up an entirely independent company to develop four of its own clinical-stage drug candidates. The …